Paper5477265
Altered platelet function in patients with prosthetic mitral valves. Effects of sulfinpyrazone therapy.
Weily HS and 1 other. Circulation, 1970. Cited by 149 papers, by iCite.
Cite this record
ConductScience Library. Altered platelet function in patients with prosthetic mitral valves. Effects of sulfinpyrazone therapy. Papers, record 5477265. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5477265
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Altered platelet function in patients with prosthetic mitral valves. Effects of sulfinpyrazone therapy.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood Coagulation Disorders | Major topic |
| Blood Platelets | Major topic |
| Heart Valve Prosthesis | Major topic |
| Mitral Valve | Major topic |
| Sulfinpyrazone | Major topic |
| Thromboembolism | Major topic |
| Adult | |
| Chromium Isotopes | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Platelet Adhesiveness |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 149 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7362733 | Effect of sulphinpyrazone on human platelet aggregation, 5-hydroxytryptamine release and adhesion ex vivo: comparison with naproxen. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7362733 | PubMed |
| 6848557 | Reversal of shortened platelet survival in rats by the antifibrinolytic agent, epsilon aminocaproic acid. | J Clin Invest | 1983 | https://conductscience.org/library/papers/6848557 | PubMed |
| 6723755 | The effect of oral administration of dipyrone on the capacity of blood platelets to synthesize thromboxane A2 in man. | Eur J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6723755 | PubMed |
| 4687370 | Platelets. | Can Med Assoc J | 1973 | https://conductscience.org/library/papers/4687370 | PubMed |
| 4450175 | Platelet survival in patients with homograft and prosthetic heart valves. Correlation with incidence of thromboembolism. | Thorax | 1974 | https://conductscience.org/library/papers/4450175 | PubMed |
| 1092540 | Platelets, thrombosis and drugs. | Drugs | 1975 | https://conductscience.org/library/papers/1092540 | PubMed |
| 834017 | [Prophylaxis and therapy of shunt thrombosis in terminal renal insufficiency (author's transl)]. | Klin Wochenschr | 1977 | https://conductscience.org/library/papers/834017 | PubMed |
| 786687 | Biotransformation and pharmacokinetics of sulfinpyrazone (Anturan) in man. | Eur J Clin Pharmacol | 1975 | https://conductscience.org/library/papers/786687 | PubMed |
| 786606 | Antithrombotic drugs: part II. | Drugs | 1976 | https://conductscience.org/library/papers/786606 | PubMed |
| 677271 | Dose-dependent inhibition of experimental arterial thrombosis by carbenicillin and ticarcillin. | Am J Pathol | 1978 | https://conductscience.org/library/papers/677271 | PubMed |
| 391530 | Antiplatelet drugs: clinical pharmacology and therapeutic use. | Drugs | 1979 | https://conductscience.org/library/papers/391530 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5477265
GET https://conductscience.org/api/papers/v1/5477265/authors